vs

Side-by-side financial comparison of ACV Auctions Inc. (ACVA) and MADRIGAL PHARMACEUTICALS, INC. (MDGL). Click either name above to swap in a different company.

MADRIGAL PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($321.1M vs $183.6M, roughly 1.7× ACV Auctions Inc.). On growth, MADRIGAL PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (210.8% vs 15.1%). ACV Auctions Inc. produced more free cash flow last quarter ($-14.7M vs $-133.8M).

ACV Auctions Inc. operates a leading digital wholesale vehicle auction platform serving automotive dealers across the U.S. and Canada. It offers end-to-end services including transparent vehicle inspections, secure payment processing, and logistics support, enabling efficient trading of used vehicles between registered wholesale buyers and sellers.

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

ACVA vs MDGL — Head-to-Head

Bigger by revenue
MDGL
MDGL
1.7× larger
MDGL
$321.1M
$183.6M
ACVA
Growing faster (revenue YoY)
MDGL
MDGL
+195.6% gap
MDGL
210.8%
15.1%
ACVA
More free cash flow
ACVA
ACVA
$119.2M more FCF
ACVA
$-14.7M
$-133.8M
MDGL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACVA
ACVA
MDGL
MDGL
Revenue
$183.6M
$321.1M
Net Profit
$-58.6M
Gross Margin
Operating Margin
-9.7%
-18.6%
Net Margin
-18.2%
Revenue YoY
15.1%
210.8%
Net Profit YoY
1.4%
EPS (diluted)
$-0.12
$-2.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACVA
ACVA
MDGL
MDGL
Q4 25
$183.6M
$321.1M
Q3 25
$199.6M
$287.3M
Q2 25
$193.7M
$212.8M
Q1 25
$182.7M
$137.3M
Q4 24
$159.5M
$103.3M
Q3 24
$171.3M
$62.2M
Q2 24
$160.6M
Q1 24
$145.7M
$0
Net Profit
ACVA
ACVA
MDGL
MDGL
Q4 25
$-58.6M
Q3 25
$-24.5M
$-114.2M
Q2 25
$-7.3M
$-42.3M
Q1 25
$-14.8M
$-73.2M
Q4 24
$-59.4M
Q3 24
$-16.0M
$-107.0M
Q2 24
$-17.1M
Q1 24
$-20.5M
$-147.5M
Gross Margin
ACVA
ACVA
MDGL
MDGL
Q4 25
Q3 25
Q2 25
Q1 25
96.7%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
ACVA
ACVA
MDGL
MDGL
Q4 25
-9.7%
-18.6%
Q3 25
-11.9%
-39.7%
Q2 25
-3.7%
-22.2%
Q1 25
-7.9%
-57.8%
Q4 24
-16.2%
-64.8%
Q3 24
-10.0%
-187.1%
Q2 24
-11.6%
Q1 24
-15.5%
Net Margin
ACVA
ACVA
MDGL
MDGL
Q4 25
-18.2%
Q3 25
-12.3%
-39.8%
Q2 25
-3.8%
-19.9%
Q1 25
-8.1%
-53.4%
Q4 24
-57.5%
Q3 24
-9.4%
-172.0%
Q2 24
-10.6%
Q1 24
-14.1%
EPS (diluted)
ACVA
ACVA
MDGL
MDGL
Q4 25
$-0.12
$-2.55
Q3 25
$-0.14
$-5.08
Q2 25
$-0.04
$-1.90
Q1 25
$-0.09
$-3.32
Q4 24
$-0.15
$-2.50
Q3 24
$-0.10
$-4.92
Q2 24
$-0.10
Q1 24
$-0.13
$-7.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACVA
ACVA
MDGL
MDGL
Cash + ST InvestmentsLiquidity on hand
$271.5M
$198.7M
Total DebtLower is stronger
$339.9M
Stockholders' EquityBook value
$429.7M
$602.7M
Total Assets
$1.1B
$1.3B
Debt / EquityLower = less leverage
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACVA
ACVA
MDGL
MDGL
Q4 25
$271.5M
$198.7M
Q3 25
$265.3M
$295.7M
Q2 25
$258.4M
$186.2M
Q1 25
$291.9M
$183.6M
Q4 24
$224.1M
$100.0M
Q3 24
$252.5M
$232.7M
Q2 24
$215.0M
Q1 24
$209.8M
$622.5M
Total Debt
ACVA
ACVA
MDGL
MDGL
Q4 25
$339.9M
Q3 25
$339.8M
Q2 25
$118.4M
Q1 25
$118.0M
Q4 24
$117.6M
Q3 24
$117.1M
Q2 24
Q1 24
$116.1M
Stockholders' Equity
ACVA
ACVA
MDGL
MDGL
Q4 25
$429.7M
$602.7M
Q3 25
$434.4M
$625.7M
Q2 25
$448.8M
$696.0M
Q1 25
$439.6M
$710.6M
Q4 24
$440.0M
$754.4M
Q3 24
$456.2M
$777.2M
Q2 24
$457.6M
Q1 24
$458.3M
$850.8M
Total Assets
ACVA
ACVA
MDGL
MDGL
Q4 25
$1.1B
$1.3B
Q3 25
$1.2B
$1.4B
Q2 25
$1.1B
$1.0B
Q1 25
$1.2B
$996.6M
Q4 24
$984.1M
$1.0B
Q3 24
$1.0B
$1.1B
Q2 24
$1.0B
Q1 24
$1.0B
$1.1B
Debt / Equity
ACVA
ACVA
MDGL
MDGL
Q4 25
0.56×
Q3 25
0.54×
Q2 25
0.17×
Q1 25
0.17×
Q4 24
0.16×
Q3 24
0.15×
Q2 24
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACVA
ACVA
MDGL
MDGL
Operating Cash FlowLast quarter
$-12.4M
$-133.5M
Free Cash FlowOCF − Capex
$-14.7M
$-133.8M
FCF MarginFCF / Revenue
-8.0%
-41.7%
Capex IntensityCapex / Revenue
1.2%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$69.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACVA
ACVA
MDGL
MDGL
Q4 25
$-12.4M
$-133.5M
Q3 25
$10.3M
$79.8M
Q2 25
$13.7M
$-47.1M
Q1 25
$66.6M
$-88.9M
Q4 24
$-3.2M
$-104.5M
Q3 24
$21.1M
$-67.0M
Q2 24
$4.5M
Q1 24
$43.0M
$-149.2M
Free Cash Flow
ACVA
ACVA
MDGL
MDGL
Q4 25
$-14.7M
$-133.8M
Q3 25
$7.7M
$79.0M
Q2 25
$10.9M
Q1 25
$65.3M
Q4 24
$-3.9M
$-104.7M
Q3 24
$20.2M
$-67.8M
Q2 24
$2.7M
Q1 24
$41.9M
$-149.5M
FCF Margin
ACVA
ACVA
MDGL
MDGL
Q4 25
-8.0%
-41.7%
Q3 25
3.8%
27.5%
Q2 25
5.6%
Q1 25
35.7%
Q4 24
-2.5%
-101.3%
Q3 24
11.8%
-109.0%
Q2 24
1.7%
Q1 24
28.8%
Capex Intensity
ACVA
ACVA
MDGL
MDGL
Q4 25
1.2%
0.1%
Q3 25
1.3%
0.3%
Q2 25
1.5%
0.0%
Q1 25
0.7%
0.0%
Q4 24
0.4%
0.2%
Q3 24
0.6%
1.3%
Q2 24
1.1%
Q1 24
0.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACVA
ACVA

Auction Marketplace Revenue$77.6M42%
Other Marketplace Revenue$72.4M39%
Customer Assurance$24.1M13%
Data Services Revenue$9.4M5%

MDGL
MDGL

Rebates Customer Fees Credits Co Pay Assistance And Other$208.5M65%
Other$76.0M24%
Chargebacks Discounts For Prompt Pay And Other Allowances$36.6M11%

Related Comparisons